Prolonged Activated Clotting Time Immediately Prior to Open Cardiac Surgery
نویسندگان
چکیده
منابع مشابه
Anesthesia in Cardiac Surgery (Open-Closed Heart)
In this paper the duties of an anesthesiologist and his right of i=;electing patient is discussed. La,ter, we di:=:cuss the <::mergencies cf heart surgery, pre up visit and alsc few dcails of pre up medication cf thei,e pati<mts. We also touch on the stages of anesthPsia and point to our preference for the use cf artery and vein for arterial and venous cannulation. In this paper we discuss in b...
متن کاملLaboratory Methodologic Approach in Prolonged Activated Partial Thromboplastin Time Test
The pathological activated partial thromboplastin time test is a data that we can find in all clinical laboratories routinely. The hemato-coagulative clinical case here reported aims to point out how the laboratory can provide a correct diagnosis by methodological rational setting and, consequently, carry out an appropriate therapy, or reassure the patient that the pathological data will not ca...
متن کاملEffect of New Heparin Potency on Activated Clotting Time during Pediatric Cardiac Surgery: A Retrospective Chart Review.
In 2009, the U.S Food and Drug Administration (FDA) announced a two-phase change in unfractionated heparin to reduce contamination and create a new potency reference. The FDA announced the change would bring about a 10% decrease in potency from the old heparin (OH) to new heparin (NH). The purpose of this article is to compare heparin in pediatric patients undergoing cardiac surgery before and ...
متن کاملArterial versus Venous Sampling for Activated Clotting Time Measurements during Open Heart
Introduction: Activated Clotting Times (ACT) are widely used for monitoring anticoagulation during open-heart surgery. It is a simple and cost-effective test performed at the bedside. However, significant variability of this test is well known. We believe that some variability in test results arises from the sample drawing site, the amount of discarded volume, and the instrument on which sample...
متن کاملResponse to letter "Evaluations of activated clotting time technologies require understanding activating clotting time system differences" by Marcia L. Zucker.
We appreciate the opportunity to respond to Dr. Zucker’s letter. We disagree with Dr. Zucker’s statement that the appropriate activating clotting time (ACT) was not chosen for the study. The ACT chosen is in the applicable clinical range over a wide variety of applications and any system must be able to accurately determine levels within this range. We also disagree that the level of variation ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Ochsner Journal
سال: 2018
ISSN: 1524-5012,1524-5012
DOI: 10.31486/toj.18.0087